ONO-5334

DB19206InvestigationalSmall molecule

ONO-5334 is under investigation in clinical trial NCT00532337 (Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis).

Chemical structure of ONO-5334
Mechanism
Curator reviewed
Formula / weight
C21H34N4O4S · 438.59 g/mol (avg)
Also known as
N-((1S)-3-((2Z)-2-((4R)-3,4-DIMETHYL-1,3-THIAZOLIDIN-2-YLIDENE)HYDRAZINO)-2,3-DIOXO-1-(TETRAHYDRO-2H-PYRAN-4YL)PROPYL)CYCLOHEPTANECARBOXAMIDE
Code names
ONO-5334

Resolves to

Compound
UNII9TDN93L9FNCAS620614-15-5ChEMBLCHEMBL4303672
Structure
InChIKeyBTZCSXIUAFVRTE-CHGLIHOBSA-NSMILESC[C@@H]1CS\C(=N/NC(=O)C(=O)[C@@H](NC(=O)C2CCCCCC2)C2CCOCC2)N1C
Targets
P43235CTSK

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with ONO-5334, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In